Department of Economics and Business Economics

Elevated polygenic burden for autism is associated with differential DNA methylation at birth

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Eilis Hannon, University of Exeter, United Kingdom
  • Diana Schendel
  • Christine Ladd-Acosta, Johns Hopkins University, United States
  • Jakob Grove
  • Christine Søholm Hansen, The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark, Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, 2300, Denmark., Lundbeck Foundation Initiative for Integrative Psychiatric Research [iPSYCH], Aarhus, Roskilde; Institute of Biological Psychiatry, MHC Sct. Hans, Mental Health Services Copenhagen, Roskilde, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • ,
  • Shan V Andrews, Johns Hopkins University, United States
  • David Michael Hougaard, Statens Serum Institut, Denmark
  • Michaeline Bresnahan, Columbia University, United States
  • Ole Mors
  • Mads Vilhelm Hollegaard, The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark, Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, 2300, Denmark., Denmark
  • Marie Bækvad-Hansen, Statens Serum Institut, Denmark
  • Mady Hornig, Columbia University, United States
  • Preben Bo Mortensen
  • Anders D Børglum
  • Thomas Werge, University of Copenhagen, Denmark
  • Marianne Giørtz Pedersen
  • Merete Nordentoft, University of Copenhagen, Denmark
  • Joseph Buxbaum, Mount Sinai School of Medicine, United States
  • M Daniele Fallin, Johns Hopkins University, United States
  • Jonas Bybjerg-Grauholm, Statens Serum Institut, Denmark
  • Abraham Reichenberg, Mount Sinai School of Medicine, United States
  • Jonathan Mill, University of Exeter, United Kingdom
  • iPSYCH-Broad ASD Group (Mette Nyegaard, Per Qvist, Jane Hvarregaard Christensen - members of -)

BACKGROUND: Autism spectrum disorder (ASD) is a severe neurodevelopmental disorder characterized by deficits in social communication and restricted, repetitive behaviors, interests, or activities. The etiology of ASD involves both inherited and environmental risk factors, with epigenetic processes hypothesized as one mechanism by which both genetic and non-genetic variation influence gene regulation and pathogenesis. The aim of this study was to identify DNA methylation biomarkers of ASD detectable at birth.

METHODS: We quantified neonatal methylomic variation in 1263 infants-of whom ~ 50% went on to subsequently develop ASD-using DNA isolated from archived blood spots taken shortly after birth. We used matched genotype data from the same individuals to examine the molecular consequences of ASD-associated genetic risk variants, identifying methylomic variation associated with elevated polygenic burden for ASD. In addition, we performed DNA methylation quantitative trait loci (mQTL) mapping to prioritize target genes from ASD GWAS findings.

RESULTS: We identified robust epigenetic signatures of gestational age and prenatal tobacco exposure, confirming the utility of DNA methylation data generated from neonatal blood spots. Although we did not identify specific loci showing robust differences in neonatal DNA methylation associated with later ASD, there was a significant association between increased polygenic burden for autism and methylomic variation at specific loci. Each unit of elevated ASD polygenic risk score was associated with a mean increase in DNA methylation of - 0.14% at two CpG sites located proximal to a robust GWAS signal for ASD on chromosome 8.

CONCLUSIONS: This study is the largest analysis of DNA methylation in ASD undertaken and the first to integrate genetic and epigenetic variation at birth. We demonstrate the utility of using a polygenic risk score to identify molecular variation associated with disease, and of using mQTL to refine the functional and regulatory variation associated with ASD risk variants.

Original languageEnglish
JournalGenome Medicine
Volume10
Issue1
Number of pages19
ISSN1756-994X
DOIs
Publication statusPublished - 2018

See relations at Aarhus University Citationformats

ID: 125904237